PERK inhibition can be a promising therapeutic strategy for neurodegenerative diseases

PERK inhibition can be a promising therapeutic strategy for neurodegenerative diseases:

Dementia Big
A major challenge in the field of neurodegeneration is the unclear understanding of neuronal dysfunction. Elucidation of these patho-mechanisms could result in the identification of novel therapeutic targets. In this article, Bell et al. present an exhaustive literature review highlighting the endoplasmic reticulum (ER) kinase PERK as a crucial contributor to systemic and neurodegenerative disorders.

http://ift.tt/1RvrepE